Skip navigation

Navigate Current Enforcement Trends and Mitigate Risks in Relationships with Payers and Specialty Pharmacies

December 5-6, 2017
  • Philadelphia, PA

Sabrina Aery
Director, 340B Compliance and State Policy
Bristol-Myers Squibb

Michelle D. Axelrod
Principal, Porzio, Bromberg & Newman, PC;
Vice President, Porzio Life Sciences, LLC

Ben Barrameda
Senior Counsel, Managed Markets and Pricing
Bayer Pharmaceuticals

Jennifer Chillas
Senior Corporate Counsel
Bristol-Myers Squibb

Jonathan Connell
Senior Counsel
Bristol-Myers Squibb

Michelle Drozd
Deputy Vice President, Policy and Research
PhRMA

Christina Flint
Vice President & General Counsel
Diplomat

Charles Graybow
Assistant U.S. Attorney
U.S. Attorney’s Office, Newark, New Jersey

Kevin M. Henley, Esq.
Senior Director, Senior Compliance Counsel
Otsuka America Pharmaceutical, Inc.

Darren Jones
Partner
Polaris

Julie K. Letwat
Counsel
Faegre Baker Daniels

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance
Bayer U.S.

Christine O’Connor-Fiore
Director, Specialty Markets Compliance
Boehringer Ingelheim

Josh O’Harra
Assistant General Counsel
Eli Lilly and Company

Curt Oltmans
Executive Vice President, General Counsel & Corporate Secretary
Array BioPharma

Jessica Rickabaugh, Esq.
Health Sciences Department
Pepper Hamilton LLP

Charles D. Rome, Esq.
Associate Director, Compliance
Novo Nordisk Inc.

Keren Tenenbaum
Assistant General Counsel
Pfizer Inc

Debbie Walters
Vice President, Assistant General Counsel
Pfizer Inc

Alonzo Weems
Vice President and Deputy General Counsel
Eli Lilly and Company

William D. Weinreb
First Assistant U.S. Attorney
District of Massachusetts

Sabrina Aery
Director, 340B Compliance and State Policy
Bristol-Myers Squibb

Michelle D. Axelrod
Principal, Porzio, Bromberg & Newman, PC;
Vice President, Porzio Life Sciences, LLC

Ben Barrameda
Senior Counsel, Managed Markets and Pricing
Bayer Pharmaceuticals

Jennifer Chillas
Senior Corporate Counsel
Bristol-Myers Squibb

Jonathan Connell
Senior Counsel
Bristol-Myers Squibb

Michelle Drozd
Deputy Vice President, Policy and Research
PhRMA

Christina Flint
Vice President & General Counsel
Diplomat

Charles Graybow
Assistant U.S. Attorney
U.S. Attorney’s Office, Newark, New Jersey

Kevin M. Henley, Esq.
Senior Director, Senior Compliance Counsel
Otsuka America Pharmaceutical, Inc.

Darren Jones
Partner
Polaris

Julie K. Letwat
Counsel
Faegre Baker Daniels

Joseph Mack
Senior Compliance Counsel, U.S. Office of Compliance
Bayer U.S.

Christine O’Connor-Fiore
Director, Specialty Markets Compliance
Boehringer Ingelheim

Josh O’Harra
Assistant General Counsel
Eli Lilly and Company

Curt Oltmans
Executive Vice President, General Counsel & Corporate Secretary
Array BioPharma

Jessica Rickabaugh, Esq.
Health Sciences Department
Pepper Hamilton LLP

Charles D. Rome, Esq.
Associate Director, Compliance
Novo Nordisk Inc.

Keren Tenenbaum
Assistant General Counsel
Pfizer Inc

Debbie Walters
Vice President, Assistant General Counsel
Pfizer Inc

Alonzo Weems
Vice President and Deputy General Counsel
Eli Lilly and Company

William D. Weinreb
First Assistant U.S. Attorney
District of Massachusetts